LCMV GP (61–80)(Cat No.:I044252)is a synthetic peptide derived from the glycoprotein (GP) of lymphocytic choriomeningitis virus (LCMV), spanning amino acids 61 to 80. This region contains a known CD8⁺ T-cell epitope and is widely used in immunological research to study antiviral T-cell responses, immune recognition, and vaccine development. LCMV GP (61–80) helps model acute and chronic viral infections, particularly in murine systems, offering insights into T-cell activation, immune memory, and viral escape mechanisms. It serves as a critical tool in understanding host-pathogen interactions and designing T-cell-based immunotherapies.